Benefits
Building Block for Muscle Protein (Adequacy, Not Extra)
Valine is one of the nine indispensable amino acids the body must have to build muscle protein, so adequate intake is necessary. That is not the same as extra valine helping. Every human measurement comes from BCAA blends, in which leucine is the component that drives the response, and a 2024 review of the human data concluded that BCAAs stimulate muscle protein synthesis less than a complete protein providing all nine indispensable amino acids. Valine on its own has never been tested.
Oxidized for Fuel in Muscle (Biochemistry, Not a Measured Performance Effect)
BCAAs including valine are oxidized in skeletal muscle during prolonged exercise, and valine's carbon skeleton enters the TCA cycle as succinyl-CoA. That is established biochemistry. It has not been shown to translate into better endurance, spared glycogen or less fatigue in any trial of valine by itself, because no such trial has been published.
Requirement and Nitrogen Balance
Human tracer studies put the average adult valine requirement at about 17 mg/kg/day; the US RDA is 24 mg/kg/day once a safety margin is added, and the WHO/FAO/UNU average requirement is 26 mg/kg/day. Below the requirement, whole-body protein balance falls off. That establishes a requirement, and ordinary food protein meets it several times over. No trial has tested supplemental valine on wound healing, surgical recovery or any catabolic illness.
Competes With Tryptophan at the Blood-Brain Barrier (No Human Outcome Tested)
Valine shares the LAT1 transporter with tryptophan, tyrosine and phenylalanine, so a large isolated dose can reduce their entry into the brain. In rats, pre-exercise L-valine blocked the exercise-induced rise in hippocampal serotonin. No human study has measured whether valine changes mood, cognition or perceived fatigue. The same transport competition is why valine can blunt levodopa, so this mechanism is at least as much a caution as a benefit.
Glucogenic Energy Substrate
Valine is purely glucogenic (converts to succinyl-CoA → glucose), unlike leucine (purely ketogenic) or isoleucine (both). Provides glucose during fasting or prolonged exercise.
Mechanism of action
BCAA Metabolism
Valine shares BCAT and BCKDH enzymes with leucine and isoleucine. Maple syrup urine disease (MSUD) results from BCKDH deficiency, accumulating BCAAs and their α-ketoacids — toxic without dietary restriction.
mTORC1 Co-Activation
Valine contributes to amino acid sensing pathways activating mTORC1, though less potently than leucine.
Glucogenic Pathway
Valine is purely glucogenic — degrades to propionyl-CoA → methylmalonyl-CoA → succinyl-CoA, entering TCA cycle for glucose synthesis. Vitamin B12 is required cofactor for the methylmalonyl-CoA mutase step.
Nitrogen Balance
Essential amino acid — required for positive nitrogen balance and protein turnover.
Clinical trials
Systematic review and meta-analysis of 18 randomized controlled trials of branched-chain amino acid blends taken around exercise-induced muscle damage. Salem A and colleagues, Sports Medicine Open, 2024. No included arm gave valine on its own.
Healthy active adults performing resistance or endurance exercise. Thirteen of the 18 included trials were rated high quality and five acceptable.
BCAA blends lowered creatine kinase immediately after exercise (Hedges g -0.44, p = 0.006) and at 72 hours (g -0.99, p = 0.002) but not at 24, 48 or 96 hours, and lowered muscle soreness at 24 hours (g -1.34), 48 hours (g -1.75), 72 hours (g -1.82) and 96 hours (g -0.82) but not immediately. Lactate dehydrogenase did not change at any time point. Soreness and blood markers were the outcomes, not endurance performance, and the supplement was a leucine-dominant blend, so none of this can be credited to valine.
GeneReviews disease chapter by Strauss KA, Puffenberger EG and Carson VJ, last updated 23 April 2020. It is a clinical reference monograph on an inherited enzyme defect, not a study, and it reports no trial of valine supplementation.
Infants and adults with maple syrup urine disease, an inherited branched-chain ketoacid dehydrogenase defect. None of it applies to a healthy person considering a supplement.
In maple syrup urine disease, total dietary protein is restricted and leucine is titrated to tolerance, while valine and isoleucine are deliberately added back and monitored on plasma amino acid levels. The chapter states that continuous valine fortification is directly related to long-term intellectual outcome. That is a prescription regimen run by a metabolic team against blood levels in people who cannot break these amino acids down. It is not a reason for anyone else to take valine, and it says nothing about whether valine helps a healthy person.